Incidence of Clinically Significant Percutaneous Spinal Cord Stimulator Lead Migration. Issue 2 (5th May 2014)

• Record Type: Journal Article
• Authors: Gazelka, Halena M.; Freeman, Eric D.; Hooten, W. Michael; Eldrige, Jason S.; Hoelzer, Bryan C.; Mauck, William D.; Moeschler, Susan M.; Pingree, Matthew J.; Rho, Richard H.; Lamer, Tim J.
• Is Part Of: Neuromodulaton. Volume 18:Issue 2(2015:Mar./Apr.)
• Page Start: 123
• Page End: 125
• Publication Date: 2014-05-05
• Subjects: Central nervous system -- Physiology -- Periodicals; Central nervous system -- Diseases -- Periodicals; 616.8
• DOI: 10.1111/ner.12184
• Languages: English
• ISSNs: 1094-7159

Abstract

<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="ner12184-sec-0001" sec-type="section"> <title>Objective</title> <p>To examine the incidence of percutaneous spinal cord stimulator lead migration, given current hardware and surgical technique.</p> </sec> <sec id="ner12184-sec-0002" sec-type="section"> <title>Materials and Methods</title> <p>We retrospectively reviewed records of patients who underwent spinal cord stimulator implantation with percutaneous leads at our institution from 2008 through 2011. We determined the number of patients who required surgical revision for clinically significant lead migration.</p> </sec> <sec id="ner12184-sec-0003" sec-type="section"> <title>Results</title> <p>Clinically significant lead migration requiring surgical revision occurred in three of 143 patients (2.1%) with primary SCS system implants utilizing percutaneous‐type leads.</p> </sec> <sec id="ner12184-sec-0004" sec-type="section"> <title>Conclusions</title> <p>The rate of lead migration observed in our practice was considerably lower than previously published estimates of clinically significant lead migration or revision for lead migration (13%–22%). However, our study did not determine the reason for the decreased rate, which may be influenced by current hardware and implant techniques.</p> </sec> </abstract>